We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer.
- Authors
Bian, S X; Kuban, D A; Levy, L B; Oh, J; Castle, K O; Pugh, T J; Choi, S; McGuire, S E; Nguyen, Q N; Frank, S J; Nguyen, P L; Lee, A K; Hoffman, K E
- Abstract
Dose-escalated (DE) radiation therapy (RT) and androgen deprivation therapy (ADT) improve prostate cancer outcomes over standard-dose RT. The benefit of adding ADT to DE-RT for men with intermediate-risk prostate cancer (IR-PrCa) is uncertain.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Vol 23, Issue 9, p2346
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mds001